Ultra-high Resolution Crystal Structure of HIV-1 Protease Mutant Reveals Two Binding Sites for Clinical Inhibitor TMC114
Journal of Molecular Biology2006Vol. 363(1), pp. 161–173
Citations Over TimeTop 10% of 2006 papers
Andrey Kovalevsky, Fengling Liu, Sofiya Leshchenko, Arun K. Ghosh, John M. Louis, Robert W. Harrison, Irene T. Weber
Related Papers
- → Solid phase synthesis of ‘head-to-tail’ cyclic peptides using a sulfonamide ‘safety-catch’ linker: the cleavage by cyclization approach(1999)68 cited
- → Decomposing the Energetic Impact of Drug Resistant Mutations in HIV-1 Protease on Binding DRV(2010)51 cited
- → Effects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir(2015)46 cited
- → Piperidine scaffold as the novel P2-ligands in cyclopropyl-containing HIV-1 protease inhibitors: Structure-based design, synthesis, biological evaluation and docking study(2020)8 cited
- → Free Energy Calculation And Decomposition Of Hiv-1 Protease-Darunavir Binding By MM-PB/GBSA And Thermodynamic Integration Method(2009)